| Meta-analysis summary statistics for associations meeting genome-wide significance | |||||||
|---|---|---|---|---|---|---|---|
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs2160860 | X-12100--hydroxytryptophan* | A/T | 7066 | 0.61 | 0.012 (0.002) | 7.35·10-11 | show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations | |
|---|---|
| SNP | rs2160860 |
| Chromosomal location | Chr8: 39,942,302 (8p11.21) |
| Gene (distance) | IDO1 (36,837) |
| Predicted causal gene | IDO1 |
| Gene/protein classification | - |
| Metabolite (Pathway) | X-12100--hydroxytryptophan* (Tryptophan metabolism; Amino acid) |
| Biochemical locus-metabolite relationship | IDO1 and IDO2 encode the two indoleamine 2,3-dioxygenase isozymes. Both enzymes take tryptophan and tryptophan-related metabolites as substrates, but IDO1 is more active [18282734]. IDO1 has known activity against 5-hydroxy-tryptophan [10833386]. X-12100 was identified as hydroxytryptophan. |
| eQTL associations | - |
| Medical information | |
|---|---|
| Complex trait associations | - |
| Known metabolite associations | - |
| Inborn error of metabolism | - |
| Pharmacological information | |
|---|---|
| ChEMBL ID | CHEMBL4685 |
| Drug information | Compounds with activity in ChEMBL |
| Locus information for top associated metabolite | |
|---|---|
HapMap2 imputation![]() | 1KGP imputation![]() |








